Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage atm kinase'

Search results for: 'research area dna damage atm kinase'

Items 231-240 of 329

Page
per page
  1. Poloxin
    A3732 Poloxin
    Target: PLK
    Summary: PLK1 inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  2. CZC-25146
    B4635 CZC-25146
    Target: LRRK2
    Summary: LRRK2 inhibitor
      ≥24.45 mg/mL
  3. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  4. LY364947
    B2287 LY364947
     1 Citation
    Summary: inhibitor of TGF-β type I receptor kinase domain
      insoluble in EtOH; insoluble in H2O; ≥24.4 mg/mL
  5. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM kinase II inhibitor, water soluble and cell permeable
      ≥29.95 mg/mL
  6. EW-7197
    B5946 EW-7197
     1 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective inhibitor of TGF-β type I receptor kinase
      ≥39.9 mg/mL
  7. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  8. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  9. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  10. Elvitegravir (GS-9137)
    A4070 Elvitegravir (GS-9137)
    Target: HIV Integrases
    Summary: HIV-1 integrase inhibitor,potent
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL

Items 231-240 of 329

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 323item
  2. Natural Products 3item
  3. Lab Reagents 2item
Specificity
  1. Selective 242item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 22item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 5item
  4. PI3K 16item
  5. Raf 10item
  6. Aurora Kinases 18item
  7. CSF-1R 4item
  8. mTOR 9item
  9. AP-1 1 item
  10. FLT3 13item
  11. GSK-3 8item
  12. PLK 6item
  13. Chk 5item
  14. Eph Receptors 2item
  15. VEGFR 30item
  16. PDGFR 22item
  17. c-Kit 12item
  18. RET 4item
  19. IRAK 1 item
  20. Bromodomain-containing proteins(BRDs) 1 item
  21. Thymidylate Synthase 1 item
  22. p38 6item
  23. PKB 1 item
  24. JNK 1 item
  25. SGK 1 item
  26. Bcr-Abl 11item
  27. MEK 3item
  28. FGFR 12item
  29. Pim 3item
  30. Voltage-gated Sodium (NaV) Channels 1 item
  31. MET 5item
  32. Src 14item
  33. Trk Receptors 2item
  34. STAT 6item
  35. Estrogen and Related Receptors 1 item
  36. EGFR 16item
  37. Reverse Transcriptases 1 item
  38. ROCK 5item
  39. BTK 1 item
  40. PAK 3item
  41. FAK 4item
  42. BMP and Other Activin Receptors 2item
  43. JAK 14item
  44. Syk 5item
  45. DNA-PK 7item
  46. AMPK 2item
  47. PDHK 1 item
  48. Topoisomerases 9item
  49. Cytochrome P450 (CYP450) 1 item
  50. ErbB 4item
  51. S6 kinases 1 item
  52. Adenosine Kinases 2item
  53. DNA Methyltransferases 2item
  54. ERK 4item
  55. c-MET 5item
  56. PKC 11item
  57. Ubiquitin-specific proteases 1 item
  58. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  59. Lyn 2item
  60. HER2 2item
  61. Pyk2 3item
  62. LRRK2 5item
  63. Insulin and Insulin-like Receptors 3item
  64. ALK 6item
  65. ROS1 1 item
  66. Sphingosine kinases (SphKs) 2item
  67. PKG 1 item
  68. PKA 4item
  69. Myosin light chain kinases (MLCKs) 1 item
  70. MELK 1 item
  71. Insulin-like growth factors (IGFs) 1 item
  72. MK2 2item
  73. Fatty-acid-binding proteins (FABPs) 1 item
  74. Angiotensin-Converting Enzymes (ACEs) 1 item
  75. Tie-2 2item
  76. RSK 2item
  77. phosphatases 1 item
  78. ATM/ATR 3item
  79. Farnesyl Diphosphate Synthases 1 item
  80. CK2 2item
  81. HIPK2 1 item
  82. HIPK3 1 item
  83. HIV Integrases 1 item
  84. P2X Receptors 1 item
  85. BLM 1 item
  86. HSV 1 item
  87. Synthases/Synthetases 2item
  88. MAGL 1 item
  89. Histamine H1 Receptors 1 item
  90. P110 1 item
  91. Hck 2item
  92. RNA Polymerases 2item
  93. MNK 1 item
  94. 5-Lipoxygenases 1 item
  95. Insulin Receptors 1 item
  96. IRG-1R 1 item
  97. Cdc2-like kinase (Clk) 1 item
  98. eEF-2 1 item
  99. Cdc7 1 item
  100. CMV 1 item
  101. ZAP-70 1 item
  102. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  103. Cytidine deaminases 1 item
  104. c-RET 3item
  105. p70 rsk 2item
  106. VEGFR3/FLT4 1 item
  107. NTRK1/TRKA 1 item
  108. CSF-1R/c-Fms 1 item
  109. TAM kinase 1 item
  110. KDR 1 item
  111. Fyn kinase 1 item
  112. AXL 1 item
  113. c-Fms tyrosine kinase 1 item
  114. insulin 1 item
  115. PPAR 1 item
  116. MSK 1 item
  117. Lyn kinase 1 item
  118. Mer tyrosine kinase 1 item
  119. ErbB-2 1 item
  120. PDK-1 1 item
  121. Histone Acetyltransferases (HATs) 1 item
  122. Prk 1 item
  123. ITK 1 item
  124. NUAK 1 item
  125. DCLK2 1 item
  126. PTK 2item
  127. phosphatidylinositol kinase 1 item
  128. prolactin secretion 1 item
  129. gonadotropin release 1 item
  130. Flk1 2item
  131. glutamate release 1 item
  132. FGR 1 item
  133. YES 2item
  134. Fyn 2item
  135. ARG 1 item
  136. TRPC channel 1 item
  137. PKD 1 item
  138. Pyruvate kinases 1 item
  139. enoyl-acyl-carrier protein reductase 1 item
  140. Rho-kinase 1 item
  141. tropomyosin receptor kinase 1 item
  142. SK 1 item
  143. PPK 1 item
  144. c-Syk 1 item
  145. CDK1/CyclinB 1 item
  146. PIM1 kinase 1 item
  147. phospholipase A2 1 item
  148. ATM 1 item
  149. Sirtuin 1 item
  150. PIKfyve 1 item
  151. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 15item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 2item
  5. Advanced Renal Cell Carcinoma 1 item
  6. Bladder Cancer 5item
  7. Bladder Carcinoma 2item
  8. Bladder Diseases 1 item
  9. B-lymphoid Malignancies 1 item
  10. Breast Cancer 48item
  11. Cancer 217item
  12. Cervical Cancer 5item
  13. Cholangiocarcinoma 2item
  14. Chronic Lymphocytic Leukemia 2item
  15. Clear Cell Renal Cell Carcinoma 1 item
  16. Colon Cancer 21item
  17. Colon Carcinoma 2item
  18. Colorectal Cancer 21item
  19. Glioblastoma 18item
  20. Glioma 6item
  21. Hepatocellular Carcinoma 5item
  22. HIV 1 item
  23. HIV Infections 2item
  24. Immunological Diseases 1 item
  25. Inflammatory Bowel Disease 1 item
  26. Inflammatory Diseases 4item
  27. Leukemia 13item
  28. Liver Cancer 3item
  29. Lung Cancer 16item
  30. Lung Carcinoma 3item
  31. Lymphoma 12item
  32. Mantle Cell Lymphoma 1 item
  33. Melanoma 15item
  34. Multiple Myeloma 5item
  35. Myelofibrosis 1 item
  36. Myeloma 2item
  37. Neuroblastoma 3item
  38. Non-small Cell Lung Cancer 5item
  39. Non-small Cell Lung Carcinoma 1 item
  40. Ovarian Cancer 19item
  41. Pancreatic Cancer 24item
  42. Prostate Cancer 18item
  43. Psoriasis 1 item
  44. Pulmonary Arterial Hypertension 1 item
  45. Renal Cancer 3item
  46. Renal Cell Carcinoma 5item
  47. Rheumatoid Arthritis 5item
  48. Sarcoma 1 item
  49. Squamous Cell Carcinoma 1 item
  50. Testicular Cancer 2item
  51. Thyroid Cancer 5item
  52. Type 2 Diabetes 3item